Brian T. Hill - Researcher Profile | RDL Research Database

Publications

2 shown

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang , Javier Muñoz , André Goy +22 more

KTE-X19 induced durable remissions in a majority of patients with relapsed or refractory mantle-cell lymphoma. The therapy led to serious and life-threatening toxic effects that...

2020 New England Journal of Medicine 1666 citations

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke , Armin Ghobadi , Caron A. Jacobson +28 more

2018 The Lancet Oncology 2108 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,774
Institution: Cleveland Clinic

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8781-3327

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.